Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study

Objective To determine the real world risk of gastrointestinal bleeding associated with the use of the novel oral anticoagulants dabigatran and rivaroxaban compared with warfarin. Design Retrospective, propensity matched cohort study. Setting: Optum Labs Data Warehouse, a large database including ad...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ
Hlavní autoři: Abraham, Neena S, Singh, Sonal, Alexander, G Caleb, Heien, Herbert, Haas, Lindsey R, Crown, William, Shah, Nilay D
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group Ltd. 2015
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4413863/
https://ncbi.nlm.nih.gov/pubmed/25910928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.h1857
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky